Meet four of the scientists testing the ChAdOx1 nCoV-19 vaccine, and find out what the first results say about safety and the immune response it creates in humans.
Scientists at the University of Oxford are developing a vaccine against COVID-19, the disease caused by the current coronavirus pandemic. They are recruiting people in the UK to take part in trials.
To ensure the ongoing affordability of generic medications for Americans, BCBS is committing $55 million to establish a partnership with Civica Rx to reduce costs of generics for consumers.
UK's risk-sharing approach to Multiple Sclerosis.